François R Girardin (François Girardin)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Topics

Angiotensin Converting Enzyme

Top Venues

Tremor and other hyperkinetic movements (New York, N.Y.)

Clinical pharmacology and therapeutics

Liver international : official journal of the International Association for the Study of the Liver

The pharmacogenomics journal

This page only lists publications with an associated author ORCID identifier.

Publications

Paul Thoueille, Susana Alves Saldanha, Fabian Schaller, Eva Choong, François Veuve, Aline Munting, Matthias Cavassini, Dominique L Braun, Huldrych F Gunthard, Jessy J Duran Ramirez, Bernard Surial, Hansjakob Furrer, Andri Rauch, Pilar Ustero, Alexandra Calmy, Marcel Stöckle, Caroline Di Benedetto, Enos Bernasconi, Patrick Schmid, Catia Marzolini, François R Girardin, Thierry Buclin, Laurent Arthur Decosterd, Monia Guidi, null null
Population Pharmacokinetics of Cabotegravir Following Oral Administration and Long-Acting Intramuscular Injection in Real-World People with HIV. Clinical pharmacology and therapeutics 115 (6) (2024)
Paul Thoueille, Susana Alves Saldanha, Fabian Schaller, Eva Choong, François Veuve, Aline Munting, Matthias Cavassini, Dominique L Braun, Huldrych F Gunthard, Jessy J Duran Ramirez, Bernard Surial, Hansjakob Furrer, Andri Rauch, Pilar Ustero, Alexandra Calmy, Marcel Stöckle, Caroline Di Benedetto, Enos Bernasconi, Patrick Schmid, Catia Marzolini, François R Girardin, Thierry Buclin, Laurent Arthur Decosterd, Monia Guidi, null null
Population Pharmacokinetics of Cabotegravir Following Oral Administration and Long-Acting Intramuscular Injection in Real-World People with HIV. Clinical pharmacology and therapeutics (2024)
Hugo Cannilla, Maria Messe, François R Girardin, François-Xavier Borruat, Julien F Bally
Drug- and Toxin-Induced Opsoclonus - a Systematized Review, including a Case Report on Amantadine-Induced Opsoclonus in Multiple System Atrophy. Tremor and other hyperkinetic movements (New York, N.Y.) 14 (2024)
Flavia Hodel, Maria B De Min, Christian Wandall Thorball, Claire Redin, Peter Vollenweider, François R Girardin, Jacques Fellay
Prevalence of actionable pharmacogenetic variants and high-risk drug prescriptions: A Swiss hospital-based cohort study. Clinical and translational science 17 (9) (2024)
Rim Marouf, Haithem Chtioui, François R Girardin, Thierry Buclin, Léonore Diezi
[Pharmacovigilance. Withdrawal and rebound effects: not just with psychotropic drugs]. Revue medicale suisse 20 (856-7) (2024)
Hugo Cannilla, Maria Messe, François R Girardin, François-Xavier Borruat, Julien F Bally
Drug- and Toxin-Induced Opsoclonus - a Systematized Review, including a Case Report on Amantadine-Induced Opsoclonus in Multiple System Atrophy. Tremor and other hyperkinetic movements (New York, N.Y.) 14 (2024)
Hugo Cannilla, Maria Messe, François R Girardin, François-Xavier Borruat, Julien F Bally
Drug- and Toxin-Induced Opsoclonus - a Systematized Review, including a Case Report on Amantadine-Induced Opsoclonus in Multiple System Atrophy. Tremor and other hyperkinetic movements (New York, N.Y.) 14 (2024)
Pierre Ekobena, Laura E Rothuizen, Francesca Bedussi, Pierre Guilcher, Sylvain Meylan, Alessandro Ceschi, François R Girardin, Kim Dao
Four cases of audio-vestibular disorders related to immunisation with SARS-CoV-2 mRNA vaccines. International journal of audiology (2022)
Cedric Follonier, Elena Tessitore, Sandra Handgraaf, David Carballo, Maëlle Achard, Antoinette Pechère-Bertschi, François Mach, François R Herrmann, François R Girardin
Cardiovascular therapy use, modification, and in-hospital death in patients with COVID-19: A cohort study. PloS one 17 (11) (2022)
Kuntheavy Ing Lorenzini, François R Girardin
Direct-acting antiviral interactions with opioids, alcohol or illicit drugs of abuse in HCV-infected patients. Liver international : official journal of the International Association for the Study of the Liver 40 (1) (2019)
François R Girardin, Antoine Poncet, Arnaud Perrier, Nathalie Vernaz, Mark Pletscher, Caroline F Samer, Jeffrey A Lieberman, Jean Villard
Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapine. The pharmacogenomics journal 19 (2) (2018)